Cannabis stocks had a door-in-the-face abrupt day Monday with broad drops across the board, led by behemoth Aphria Inc (NYSE:APHA), which swung to a wide loss in its third-quarter financial results, despite a huge boost in revenue.
The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, closed down 3.6% to 284.54. The Horizons Marijuana Life Sciences Index ETF was down 4.5% at C$19.89.
Duds
Aphria Inc (TSE:APHA) (NYSE:APHA) was the talk of the town Monday after the Canadian producer swung to a loss in its fiscal third-quarter despite posting sharply higher revenue.
Shares were down 14.2% at C$ 11.50 in Toronto and slid 14.9% at US$8.60 in New York.
READ: Aphria shares dip after cannabis producer swings to fiscal 3Q loss
Its net loss for the three months to February 28 came to C$108.2 million (US$81.1 million) or C$0.43 per share, down from a profit of C$12.9 million (US$9.69 million), or C$0.08 per share, in the year-ago quarter. Its bottom-line took a hit from a $50 million charge related to its Latin American assets.
Its net revenue, meanwhile, climbed to $73.6 million, jumping more than sevenfold from $10.27 million in the year-ago quarter.
The Ontario company also posted a decline in the number of kilograms of cannabis sold in the quarter to 2,636.5 from 3,408.9, despite its average selling price rising to C$8.03 per gram from C$7.51 per gram due to higher cannabis oil sales.
Other laggards Monday included Cronos Group Inc (NASDAQ:CRON) (TSE:CRON), which sank 6.6% at C$21.18 in Toronto and down 7.4% at US$15.78 in New York.
Cronos has been dogged by disappointing earnings released a few weeks ago which missed expectations, alongside a host of analyst downgrades. The stock has dropped around 20% since the start of 2019.
Other decliners included Aleafia Health Inc (OTSMKTS:ALEAF) (CVE:ALEF), which was down 7.1% at US$1.16 in New York and down 7.7% at C$1.55 in Toronto.
Buds
Valens GroWorks Corp (CSE:VGW) (OTCMKTS:VGWCF) bucked the trend on Monday, with shares up 8.4% at C$3.75 in Toronto and up 7.2% at C$2.80 in New York.
Last week, the Kelowna-based company announced it had raised a substantial $43 million to expand its geographic presence and increase production capacity. Valens has extraction processing and supply agreements with a number of leading producers across Canada.
WATCH: Valens GroWorks raises over 43 million dollars to grow expansion
Chemistree Technology Inc (CSE:CHM) (OTCMKTS:CHMJF) saw shares jump on Monday as it announced a partnership to potentially expand its presence outside California and Washington state.
The cannabis-focused investment group said its US subsidiary, American CHM Investments Inc, has signed a letter of intent (LOI) to partner with Applied Cannabis Sciences of New Jersey (ACS).
Shares were up 6.8% at C$0.63 in Toronto and up 10.2% at C$0.47 in New York.
READ: Chemistree Technology shares advance as it sets to partner with Applied Cannabis Sciences of New Jersey
Contact Katie Lewis at katie@proactiveinvestors.com